
    
      Obese individuals with elevated PAI-1 levels (greater than 10 ng/ml) are randomized to
      pentoxifylline 400mg, three times a day (TID) or placebo for 8 weeks. PAI-1, TNF-a and high
      sensitivity C-Reactive Protein are measured at week 0, 4 and 8.
    
  